This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has ... isthmus-dependent atrial flutter. "The Affera system was designed to address ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

Changes in the heart's electrical system are what cause atrial flutter. As mentioned above, the recent episode is not unfamiliar territory for Harbaugh. The football coach had ablation ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

A cardiac ablation is a treatment for irregular heartbeats ... weeks after leaving his team's game on Sunday with an "atrial flutter." Harbaugh left the sideline during the first quarter of ...

and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.